2m 2m 2m 2m 2m 2m 2m
NEUROPACE (NPCE)
NASDAQ
$16.37-$0.75 (-4.38%)
Price as of Jul 14, 2026 12:55 PM EDT- $583.7MMarket Cap
- 79.27%1-Year Change
- Medical DevicesIndustry
NEUROPACE (NPCE)
$16.37-$0.75 (-4.38%)
NPCE | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $17.12 | ||
Change | +$0.01 (+0.06%) | ||
Open | $17.22 | ||
High | $17.58 | ||
Low | $16.95 | ||
Previous Close | $17.11 | ||
Volume | 97,375 | ||
30-Day Average Volume | 197,835 | ||
1-Week Change | -1.21% | ||
1-Month Change | 9.46% | ||
1-Year Change | 79.27% | ||
3-Year Change | 307.62% | ||
5-Year Change | -31.71% | ||
Fundamentals | |||
Shares Outstanding | 34.1M | ||
Total Assets | $98.9M | ||
Market Cap | $583.7M | ||
Enterprise Value | $627.9M | ||
Period: QTR TTM FY | |||
Revenue | $22.1M | ||
Net Income | -$6.7M | ||
Free Cash Flow | -$6.0M | ||
EBIT | -$5.2M | ||
EBITDA | -$5.1M | ||
Net Working Capital | $70.8M | ||
EPS | -$0.20 | ||
Enterprise Value/EBITDA | -122 | ||
Enterprise Value/Revenue | 28 | ||
P/B | 40 | ||
P/E | -86 | ||
PEG | 1 | ||
Price/Free Cash Flow | -97 | ||
Price/Operating Cash Flow | -99 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue